News

Currently, solithromycin is in Phase III development for the treatment of CABP and submission of a new drug application (NDA) is planned for 2016. The company is carrying

Earlier, drisapersen has also secured orphan and fast track status, breakthrough therapy designation, as well as priority review status from the FDA. According to FDA, a rare pediatric

The deal will see Valeant pay all cash, one $500m installment upfront and the remaining next year to Sprout, according to the Wall Street Journal. Under the deal,

Developed for the prescription market and formulated with the patented Microcyn Technology, the product is being made available via the company’s dermatology division IntraDerm Pharmaceuticals. Alevicyn SG Antipruritic

Kineret has been approved for the treatment of systemic juvenile idiopathic arthritis (SJIA), which is a rare form of juvenile chronic arthritis that affects children up to 16

Researchers found that being overweight more than doubled the risk of bowel cancer in people with Lynch Syndrome, an inherited genetic disorder which affects genes responsible for detecting

The transaction will continue to bolster Hi-Tech’s leading Sports Nutrition and Weight Loss arsenal and expand its position as the leader in Diet & Energy products and continues

Known as ‘Social Impact Metrics’, the MBA course is created with a view to help nonprofit organizations measure effectiveness of their drives, stated to be critical in keeping

The company has recalled the products as the bottle cap can be cracked open by children who can gain unintended access to the capsules that are used for